PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.
Long LL, Ma SC, Guo ZQ, Zhang YP, Fan Z, Liu LJ, Liu L, Han DD, Leng MX, Wang J, Guo XJ, Tan JL, Cai XT, Lin Y, Pan X, Wu DH, Bai X, Dong ZY.
Long LL, et al. Among authors: wu dh.
Cancer Res. 2023 Feb 15;83(4):568-581. doi: 10.1158/0008-5472.CAN-22-1740.
Cancer Res. 2023.
PMID: 36512628